Showing 6281-6290 of 7669 results for "".
Nanotechnology: Delivering Undeliverables
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/nanotechnology-delivering-undeliverables/18821/Adam Friedman, MD discusses the potential benefits of nitric oxide (NO) in wound healing, anti-inflammation, and in stopping itch and pain, among many others. Dr. Friedman provides an update on research into the use of nanotechnology in enhancing our ability to deliver it and his own work in using nPhysician Spotlight
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight/21039/The media is quick to use the phrase “game changer” whenever a new body-contouring device or technique enters the fray. An expert weighs in.When to Consider Therapeutic Switching in Plaque Psoriasis: Best Practices for Nurse Practitioners, Physician Assistants, and Physicians
https://practicaldermatology.com/topics/psoriasis/when-to-consider-therapeutic-switching-in-plaque-psoriasis-best-practices-for-nurse-practitioners-physician-assistants-and-physicians/21054/What to know about patient experiences and the proper approaches to modifying treatment regimens.New Biologics
https://practicaldermatology.com/topics/psoriasis/new-biologics/18635/Craig Leonardi, MD, shares insight on developments in biologics that may offer significantly improved efficacy compared with existing agents. Dr. Leonardi also discusses the rapidly evolving treatment paradigm in the management of psoriasis.Superficial Radiation for Keloids: SRT-100 in Practice
https://practicaldermatology.com/topics/skin-cancer-photoprotection/superficial-radiation-for-keloids-srt-100-in-practice/19040/Keloids are common. Certain patients, especially patients of color, are more prone to the development of keloids in certain locations, especially areas such as the chest, back, and other areas. Most studies that show that keloids can occur in up to 90 percent of cases when they're excised. The use oBiologics and Pediatric Psoriasis
https://practicaldermatology.com/topics/practice-management/biologics-and-pediatric-psoriasis/21196/Though data has been lacking in recent years, the use of biologics in pediatric and adolescent patients deserves more consideration.Part 3: New Developments in Biologics
https://practicaldermatology.com/topics/psoriasis/part-3-new-developments-in-biologics/18965/In this edition of Derm Insider, host Neal Bhatia, MD tackles the evolving systemic treatment landscape for psoriasis with guests Alice Gottlieb, MD, Harold Farber, MD, and James Ulery, MD. In Part III, they discuss new developments in biologic therapy.Bellafill Fills a Niche; Soolantra Targets Rosacea
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-bellafill-fills-a-niche-soolantra-targets-rosacea-/18995/In this edition of DermWireTV from the editors of Practical Dermatology® magazine, a look at the approval of Bellafill (Suneva) to treat acne scars and Soolantra (Ivermectin 1%, Galderma) to treat rosacea. Plus, Benzac (Galderma) is now available OTC to treat acne, and Opdivo (Bristol-Myers Squibb)2014 Year in Review: Actinic Keratosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/2014-year-in-review-actinic-keratosis/19003/Neal Bhatia, MD discusses the management of actinic keratosis in 2014. He also offers a look at what's ahead for the specialty as a whole in 2015.2014 Fourth Quarter Tax Saving Tips
https://practicaldermatology.com/topics/practice-management/2014-fourth-quarter-tax-saving-tips/21294/What to do now to save $10,000-$25,000 or more on your 2014 taxes.